These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10523129)

  • 21. Tuberculosis. Part II.
    LoBue PA; Catanzaro A; Dutt AK; Stead W
    Dis Mon; 1997 Apr; 43(4):181-274. PubMed ID: 9146474
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Pasipanodya JG; Srivastava S; Gumbo T
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205. PubMed ID: 25361414
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of Multidrug-resistant Tuberculosis Infection in Children.
    Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
    Pediatr Infect Dis J; 2018 Aug; 37(8):831-834. PubMed ID: 29742640
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-tuberculosis drug resistance in Dohuk, Iraq.
    Merza MA; Farnia P; Masjedi MR; Ridell M
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1213-4. PubMed ID: 20819274
    [No Abstract]   [Full Text] [Related]  

  • 25. In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Garcia-Prats AJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205-6. PubMed ID: 25361415
    [No Abstract]   [Full Text] [Related]  

  • 26. Why is long-term therapy required to cure tuberculosis?
    Connolly LE; Edelstein PH; Ramakrishnan L
    PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multidrug-resistant tuberculosis in Romania].
    Stoicescu IP; Didilescu C; Bercea O
    Pneumoftiziologia; 1997; 46(3):161-78. PubMed ID: 9654954
    [No Abstract]   [Full Text] [Related]  

  • 28. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
    Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A
    Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of resistance in multi drug resistant tuberculosis patients.
    Irfan S; Hassan Q; Hasan R
    J Pak Med Assoc; 2006 Sep; 56(9):397-400. PubMed ID: 17091751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Occurence of primary resistance in hospital patients with respiratory tuberculosis].
    Serdarević H; Bogdanović M; Travnik H; Simeonov L
    Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090
    [No Abstract]   [Full Text] [Related]  

  • 32. Pakistan's battle with multi-drug resistant tuberculosis--establishing the ground rules.
    Saleem T; Khalid U
    J Pak Med Assoc; 2012 Jan; 62(1):80. PubMed ID: 22352115
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
    Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt.
    Abbadi S; Rashed HG; Morlock GP; Woodley CL; El Shanawy O; Cooksey RC
    J Clin Microbiol; 2001 Jun; 39(6):2330-4. PubMed ID: 11376084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Difficulties in the treatment of pulmonary tuberculosis in children].
    Brînză N; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy.
    Fattorini L; Migliori GB; Cassone A; Mustazzolu A; Piccaro G; Filippini P; Cirillo DM; Borroni E;
    Eur Respir J; 2012 May; 39(5):1263-6. PubMed ID: 22547735
    [No Abstract]   [Full Text] [Related]  

  • 40. [M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
    Novozhylova IO
    Lik Sprava; 2003 Dec; (8):16-20. PubMed ID: 14964999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.